Short interest in CytomX Therapeutics, Inc. (NASDAQ: CTMX) decreased by 21.7% in November.

CytomX Therapeutics, Inc. (NASDAQ:CTMX – Get Free Report) saw a significant decline in short interest in the month of November. As of November 15th, there was short interest totalling 4,440,000…

Read More: https://www.marketbeat.com/instant-alerts/cytomx-therapeutics-inc-nasdaqctmx-short-interest-down-217-in-november-2024-11-30/